In our study, we saw how the two markers have statistically significant expression in cancer cells but not in peritumoral thyrocytes and inflammatory cells, confirming the hypothesis that as NFkB expression increases, CD25 transcription increases but also that, conversely, the inflammatory microenvironment present in thyroid cancer supports NFkB-mediated carcinogenesis. This evidence concerns the gene NFKB1 and cancer.